Insider Trading activities of Provectus Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Provectus Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Provectus Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Provectus Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is PVCT. The reporting company's CIK number is 315545.
The total value of stock buying since 2005 is $974,328.
The total value of stock sales since 2005 is $398,870.
The total value of stock option exercises since 2005 is $5,170,426.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Provectus Pharmaceuticals Inc (PVCT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-12 0 $0 0 $0 265,214 $258,901
2015-01 0 $0 0 $0 324,884 $291,164
2014-12 0 $0 0 $0 126,361 $80,871
2014-10 0 $0 0 $0 96,875 $62,000
2014-06 0 $0 0 $0 100,000 $125,000
2014-05 0 $0 0 $0 25,000 $23,750
2014-03 0 $0 0 $0 639,248 $560,620
2014-02 0 $0 0 $0 489,624 $538,586
2013-09 100,000 $0 0 $0 0 $0
2013-05 0 $0 0 $0 43,750 $20,125
2012-12 133,333 $0 0 $0 0 $0
2012-11 799,999 $0 0 $0 0 $0
2011-12 0 $0 0 $0 200,000 $168,000
2011-11 0 $0 0 $0 100,000 $93,000
2011-10 0 $0 0 $0 200,000 $139,000
2011-09 0 $0 0 $0 100,000 $93,000
2011-05 0 $0 0 $0 233,333 $199,999
2011-04 0 $0 0 $0 250,000 $250,000
2011-02 0 $0 0 $0 133,333 $99,999
2010-12 0 $0 0 $0 533,333 $499,999
2010-11 0 $0 0 $0 100,000 $100,000
2010-09 0 $0 0 $0 100,000 $100,000
2010-07 0 $0 0 $0 75,000 $82,500
2010-04 0 $0 0 $0 157,888 $109,732
2009-12 0 $0 0 $0 98,334 $96,367
2009-08 0 $0 0 $0 50,000 $47,000
2009-07 0 $0 0 $0 20,000 $20,400
2009-06 0 $0 0 $0 259,375 $166,000
2008-11 0 $0 0 $0 66,666 $62,666
2008-06 0 $0 0 $0 74,795 $79,874
2008-05 0 $0 0 $0 63,281 $39,867
2008-04 0 $0 0 $0 100,000 $46,000
2007-12 0 $0 0 $0 330,881 $309,373
2007-11 0 $0 0 $0 50,000 $32,000
2007-09 0 $0 120,000 $318,560 34,375 $19,000
2007-08 0 $0 0 $0 84,375 $51,000
2007-07 0 $0 0 $0 6,250 $2,000
2007-04 0 $0 4,630 $6,793 0 $0
2007-03 0 $0 10,000 $11,940 9,375 $3,000
2007-02 0 $0 20,772 $23,507 120,920 $133,012
2007-01 679,048 $713,000 17,500 $21,120 0 $0
2006-11 0 $0 0 $0 3,500 $3,850
2006-10 0 $0 0 $0 3,500 $3,850
2006-09 0 $0 0 $0 3,500 $3,850
2006-08 0 $0 15,000 $16,950 6,625 $4,850
2006-07 0 $0 0 $0 7,000 $7,700
2006-06 0 $0 0 $0 6,250 $2,000
2006-05 40,000 $62,800 0 $0 6,625 $4,850
2006-04 0 $0 0 $0 6,791 $5,032
2006-03 0 $0 0 $0 26,064 $28,669
2006-02 0 $0 0 $0 3,734 $4,107
2006-01 0 $0 0 $0 85,181 $93,697
2005-12 264,705 $198,528 0 $0 3,788 $4,166

Table 2. Detailed insider stock purchases, sales, and option exercises of Provectus Pharmaceuticals Inc insiders (PVCT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-12-21 Wachter Eric Phd (Chief Technology Officer) Option Ex 120,000 1.02 122,400
2015-12-09 Culpepper Peter R (CFO & COO) Option Ex 145,214 .94 136,501
2015-01-24 Wachter Eric Phd (Chief Technology Officer) Option Ex 185,000 1.02 188,700
2015-01-07 Culpepper Peter R (CFO & COO) Option Ex 63,120 .84 53,336
2015-01-07 Scott Timothy Phd (President) Option Ex 76,764 .64 49,128
2014-12-30 Scott Timothy Phd (President) Option Ex 126,361 .64 80,871
2014-10-29 Scott Timothy Phd (President) Option Ex 96,875 .64 62,000
2014-06-28 Culpepper Peter R (CFO & COO) Option Ex 100,000 1.25 125,000
2014-05-19 Scott Timothy Phd (President) Option Ex 25,000 .95 23,750
2014-03-20 Wachter Eric Phd (Chief Technology Officer) Option Ex 639,248 .88 560,620
2014-02-26 Culpepper Peter R (CFO & COO) Option Ex 189,624 1.10 208,586
2014-02-26 Scott Timothy Phd (President) Option Ex 300,000 1.10 330,000
2013-09-20 Koe Jan Buy 100,000 .00 0
2013-05-29 Dees H Craig (Chief Executive Officer) Option Ex 43,750 .46 20,125
2012-12-03 Culpepper Peter R (CFO, COO) Buy 133,333 .00 0
2012-11-16 Culpepper Peter R (CFO, COO) Buy 133,333 .00 0
2012-11-16 Wachter Eric Phd (Chief Technology Officer) Buy 666,666 .00 0
2011-12-05 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 100,000 .75 75,000
2011-12-01 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 100,000 .93 93,000
2011-11-23 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 100,000 .93 93,000
2011-10-19 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 100,000 .93 93,000
2011-10-06 Scott Timothy Phd (President) Option Ex 100,000 .46 46,000
2011-09-07 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 100,000 .93 93,000
2011-05-03 Culpepper Peter R (Chief Financial Officer) Option Ex 133,333 .75 99,999
2011-05-03 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 100,000 1.00 100,000
2011-04-20 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 100,000 1.00 100,000
2011-04-12 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 150,000 1.00 150,000
2011-02-07 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 8,333 .75 6,249
2011-02-03 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 125,000 .75 93,750
2010-12-29 Culpepper Peter R (Chief Financial Officer) Option Ex 133,333 .75 99,999
2010-12-29 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 400,000 1.00 400,000
2010-11-19 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 100,000 1.00 100,000
2010-09-07 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 100,000 1.00 100,000
2010-07-09 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 75,000 1.10 82,500
2010-04-28 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 157,888 .70 109,732
2009-12-22 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 98,334 .98 96,367
2009-08-26 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 50,000 .94 47,000
2009-07-17 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 20,000 1.02 20,400
2009-06-11 Culpepper Peter R (Chief Financial Officer) Option Ex 150,000 .64 96,000
2009-06-08 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 109,375 .64 70,000
2008-11-20 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 66,666 .94 62,666
2008-06-24 Wachter Eric Phd (Executive VP Pharmaceuticals) Option Ex 30,000 1.02 30,600
2008-06-12 Culpepper Peter R (Chief Financial Officer) Option Ex 44,795 1.10 49,274
2008-05-30 Wachter Eric Phd (Executive VP Pharmaceuticals) Option Ex 63,281 .63 39,867
2008-04-09 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 100,000 .46 46,000
2007-12-27 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 330,881 .94 309,373
2007-11-12 Culpepper Peter R (Chief Financial Officer) Option Ex 50,000 .64 32,000
2007-09-22 Adams Donald E (10% Owner) Sale 5,000 2.98 14,900
2007-09-13 Culpepper Peter R (Chief Financial Officer) Option Ex 25,000 .64 16,000
2007-09-13 Dees H Craig (Chief Executive Officer) Option Ex 9,375 .32 3,000
2007-09-06 Adams Donald E (10% Owner) Sale 70,000 2.89 202,160
2007-09-05 Adams Donald E (10% Owner) Sale 25,000 2.40 60,000
2007-09-04 Adams Donald E (10% Owner) Sale 20,000 2.08 41,500
2007-08-23 Culpepper Peter R (Chief Financial Officer) Option Ex 75,000 .64 48,000
2007-08-23 Dees H Craig (Chief Executive Officer) Option Ex 9,375 .32 3,000
2007-07-02 Dees H Craig (Chief Executive Officer) Option Ex 6,250 .32 2,000
2007-04-11 Adams Donald E (10% Owner) Sale 630 1.45 913
2007-04-03 Adams Donald E (10% Owner) Sale 4,000 1.47 5,880
2007-03-21 Adams Donald E (10% Owner) Sale 2,000 1.29 2,580
2007-03-19 Adams Donald E (10% Owner) Sale 2,000 1.24 2,480
2007-03-09 Dees H Craig (Chief Executive Officer) Option Ex 9,375 .32 3,000
2007-03-07 Adams Donald E (10% Owner) Sale 4,000 1.15 4,600
2007-03-02 Adams Donald E (10% Owner) Sale 2,000 1.14 2,280
2007-02-23 Adams Donald E (10% Owner) Sale 2,000 1.14 2,280
2007-02-20 Adams Donald E (10% Owner) Sale 2,000 1.13 2,260
2007-02-15 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 120,920 1.10 133,012
2007-02-13 Adams Donald E (10% Owner) Sale 8,000 1.12 8,960
2007-02-07 Adams Donald E (10% Owner) Sale 4,772 1.15 5,487
2007-02-06 Adams Donald E (10% Owner) Sale 4,000 1.13 4,520
2007-01-31 Adams Donald E (10% Owner) Sale 2,000 1.17 2,340
2007-01-27 Adams Donald E (10% Owner) Buy 679,048 1.05 713,000
2007-01-24 Adams Donald E (10% Owner) Sale 1,500 1.20 1,800
2007-01-22 Adams Donald E (10% Owner) Sale 6,000 1.20 7,200
2007-01-17 Adams Donald E (10% Owner) Sale 2,000 1.23 2,460
2007-01-16 Adams Donald E (10% Owner) Sale 6,000 1.22 7,320
2006-11-30 Culpepper Peter R (Chief Financial Officer) Option Ex 3,500 1.10 3,850
2006-10-30 Culpepper Peter R (Chief Financial Officer) Option Ex 3,500 1.10 3,850
2006-09-28 Culpepper Peter R (Chief Financial Officer) Option Ex 3,500 1.10 3,850
2006-08-30 Culpepper Peter R (Chief Financial Officer) Option Ex 3,500 1.10 3,850
2006-08-11 Adams Donald E (10% Owner) Sale 15,000 1.13 16,950
2006-08-01 Dees H Craig (Chief Executive Officer) Option Ex 3,125 .32 1,000
2006-07-30 Culpepper Peter R (Chief Financial Officer) Option Ex 3,500 1.10 3,850
2006-07-05 Culpepper Peter R (Chief Financial Officer) Option Ex 3,500 1.10 3,850
2006-06-05 Dees H Craig (Chief Executive Officer) Option Ex 6,250 .32 2,000
2006-05-30 Culpepper Peter R (Chief Financial Officer) Option Ex 3,500 1.10 3,850
2006-05-30 Dees H Craig (Chief Executive Officer) Option Ex 3,125 .32 1,000
2006-05-24 Adams Donald E (10% Owner) Buy 40,000 1.57 62,800
2006-04-30 Culpepper Peter R (Chief Financial Officer) Option Ex 3,666 1.10 4,032
2006-04-21 Dees H Craig (Chief Executive Officer) Option Ex 3,125 .32 1,000
2006-03-31 Culpepper Peter R (Chief Financial Officer) Option Ex 3,666 1.10 4,032
2006-03-31 Wachter Eric Phd (Vice President Pharmaceuticals) Option Ex 22,398 1.10 24,637
2006-02-28 Culpepper Peter R (Chief Financial Officer) Option Ex 3,734 1.10 4,107
2006-01-31 Culpepper Peter R (Chief Financial Officer) Option Ex 3,499 1.10 3,848
2006-01-31 Wachter Eric Phd (Vice President Pharm) Option Ex 39,703 1.10 43,673
2006-01-04 Wachter Eric Phd (Vice President Pharm) Option Ex 41,979 1.10 46,176
2005-12-31 Culpepper Peter R (Chief Financial Officer) Option Ex 3,788 1.10 4,166
2005-12-09 Wachter Eric Phd (Vice President Pharm) Buy 264,705 .75 198,528

Insider trading activities including stock purchases, stock sales, and option exercises of PVCT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Provectus Pharmaceuticals Inc (symbol PVCT, CIK number 315545) see the Securities and Exchange Commission (SEC) website.